TABLE 2.
Measured parameters (mean ± SD) and comparison between cavity+ group and cavity− group
| Parameter | Value for group
|
P valuea | ||
|---|---|---|---|---|
| Total | Cavity+ | Cavity− | ||
| TBGL-IgG (U/ml) | 13.2 ± 23.5 | 17.1 ± 27.6 | 6.0 ± 9.9 | <0.005* |
| TBGL-IgA (U/ml) | 22.6 ± 95.4 | 32.0 ± 117.2 | 5.3 ± 15.7 | <0.05* |
| TBGL-IgM (U/ml) | 6.0 ± 5.6 | 5.9 ± 5.8 | 6.2 ± 5.3 | NS |
| IgG (mg/dl) | 1,518 ± 471 | 1,523 ± 510 | 1,509 ± 395 | NS |
| IgA (mg/dl) | 416 ± 213 | 451 ± 236 | 348 ± 140 | <0.05* |
| IgM (mg/dl) | 106 ± 57 | 103 ± 58 | 111 ± 55 | NS |
| White blood cells/μl | 7,236 ± 2,706 | 7,830 ± 3,020 | 6,141 ± 1,513 | <0.01* |
| Neutrophils/μl | 5,567 ± 2,532 | 6,192 ± 2,798 | 4,415 ± 1,362 | <0.005* |
| Monocytes/μl | 397 ± 223 | 424 ± 243 | 347 ± 172 | NS |
| Eosinophils/μl | 115 ± 119 | 126 ± 135 | 94 ± 80 | NS |
| Basophils/μl | 24 ± 45 | 22 ± 46 | 29 ± 43 | <0.0005* |
| Lymphocytes/μl | 1,128 ± 740 | 1,061 ± 766 | 1,253 ± 685 | NS |
| CD3+ cells/μl | 751 ± 509 | 715 ± 517 | 815 ± 496 | NS |
| CD20+ cells/μl | 131 ± 115 | 114 ± 93 | 161 ± 143 | NS |
| CD56+ cells/μl | 208 ± 197 | 197 ± 223 | 231 ± 140 | <0.05* |
| CRP (mg/dl) | 4.5 ± 5.2 | 5.7 ± 5.8 | 2.2 ± 2.9 | <0.0005* |
| KL-6 (U/ml) | 564 ± 459 | 662 ± 518 | 382 ± 241 | <0.0005* |
| sCD40L (ng/ml) | 1.8 ± 2.5 | 2.1 ± 3.0 | 1.2 ± 1.0 | <0.01* |
| Creatinine (mg/ml) | 1.0 ± 1.5 | 0.8 ± 0.6 | 1.5 ± 2.4 | NS |
| Albumin (g/dl) | 3.4 ± 0.8 | 3.3 ± 0.7 | 3.6 ± 0.8 | NS |
a
Asterisks show significant differences between the cavity+ group and the cavity− group. NS, no significant difference. The significances of differences were evaluated by the Mann-Whitney test. P values of <0.05 were considered significant.